
Tesseract Medical Research
Tesseract - Preventative & Nutritional Supplementation.
Date | Investors | Amount | Round |
---|---|---|---|
* | $20.0m | Seed | |
Total Funding | 000k |
Related Content
Tesseract Medical Research, founded in 2016 by Al Czap, is a life sciences company focused on advancing health through nutraceuticals. Czap, who previously founded and led Thorne Research, established Tesseract with the goal of overcoming common obstacles in nutrient supplementation, such as low bioavailability and poor tolerance. His experience in creating pure, allergen-free formulations at Thorne set the stage for his work at Tesseract, where he continues to address the challenge of delivering beneficial molecules effectively.
The company operates in the nutraceutical and medical food markets, serving both healthcare practitioners and consumers directly. Its business model centers on the development and sale of supplements that utilize a proprietary, patent-pending nutrient delivery system. In 2023, Tesseract acquired the tolling and operations business from Pulse Combustion Systems, a move intended to give it greater control over its manufacturing processes, which are crucial for its core business. This vertical integration reflects a strategy to manage and scale the production of its specialized products.
Tesseract's core offering is its advanced delivery technology, which enhances the absorption of active ingredients. This system involves a two-step process named CyLoc® and DexKey®. First, the CyLoc® technology encases individual molecules of an ingredient in a dextrin fiber matrix, protecting them through the digestive system and masking any unpalatable taste or odor. Then, the DexKey® process facilitates the release of the active ingredient at the desired point in the intestinal tract for optimal absorption. This allows for lower, more effective doses, a concept the company refers to as micro-dosing. Products incorporating this technology include ProButyrate® for gastrointestinal health, QuerciSorb™ for immune response, and AuRx®, a medical food developed for individuals on the Autism Spectrum.
Keywords: nutrient delivery, nutraceuticals, bioavailability, Al Czap, medical food, dietary supplements, gut health, microbiome, CyLoc, DexKey, ProButyrate, Thorne Research, supplement absorption, controlled release, particle engineering, molecular encapsulation, practitioner supplements, nano-nutrient delivery, gastrointestinal support, immune support